Amalgamated Bank Buys 1,811 Shares of UiPath Inc. (NYSE:PATH)

Amalgamated Bank lifted its stake in UiPath Inc. (NYSE:PATH) by 7.1% in the third quarter, Holdings Channel.com reports. The firm owned 27,312 shares of the healthcare company’s stock after buying an additional 1,811 shares during the period. Amalgamated Bank’s holdings in UiPath were worth $350,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of PATH. Global Financial Private Client LLC boosted its stake in UiPath by 9.3% during the first quarter. Global Financial Private Client LLC now owns 6,471 shares of the healthcare company’s stock worth $144,000 after buying an additional 551 shares during the period. Advisors Asset Management Inc. grew its holdings in UiPath by 35.0% during the 1st quarter. Advisors Asset Management Inc. now owns 3,037 shares of the healthcare company’s stock valued at $69,000 after purchasing an additional 787 shares during the last quarter. Empowered Funds LLC grew its holdings in UiPath by 10.5% during the 1st quarter. Empowered Funds LLC now owns 10,856 shares of the healthcare company’s stock valued at $246,000 after purchasing an additional 1,033 shares during the last quarter. State Board of Administration of Florida Retirement System raised its position in UiPath by 0.5% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 295,370 shares of the healthcare company’s stock worth $6,696,000 after purchasing an additional 1,571 shares during the period. Finally, Bangor Savings Bank lifted its stake in UiPath by 2.9% in the second quarter. Bangor Savings Bank now owns 67,040 shares of the healthcare company’s stock worth $850,000 after purchasing an additional 1,873 shares during the last quarter. Institutional investors own 62.50% of the company’s stock.

Insider Buying and Selling at UiPath

In related news, CFO Ashim Gupta sold 47,671 shares of the company’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $12.07, for a total transaction of $575,388.97. Following the transaction, the chief financial officer now directly owns 849,917 shares of the company’s stock, valued at $10,258,498.19. This represents a 5.31 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 22.37% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on PATH. Needham & Company LLC reiterated a “hold” rating on shares of UiPath in a report on Wednesday, October 23rd. TD Cowen reduced their target price on UiPath from $17.00 to $16.00 and set a “hold” rating on the stock in a research note on Friday, September 6th. Wells Fargo & Company decreased their target price on UiPath from $15.00 to $13.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 23rd. BMO Capital Markets upped their price target on shares of UiPath from $14.00 to $15.00 and gave the stock a “market perform” rating in a report on Friday, September 6th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $16.00 price objective on shares of UiPath in a report on Friday, September 6th. Sixteen research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $17.47.

UiPath Stock Down 2.1 %

UiPath stock opened at $12.37 on Monday. The firm has a market cap of $6.80 billion, a P/E ratio of -61.85 and a beta of 0.87. The business has a fifty day moving average of $12.61 and a two-hundred day moving average of $13.34. UiPath Inc. has a twelve month low of $10.37 and a twelve month high of $27.87.

UiPath (NYSE:PATH) last released its quarterly earnings results on Thursday, September 5th. The healthcare company reported $0.04 EPS for the quarter, beating the consensus estimate of $0.03 by $0.01. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The business had revenue of $316.00 million during the quarter, compared to analyst estimates of $303.69 million. During the same period in the prior year, the firm posted ($0.09) earnings per share. The company’s quarterly revenue was up 10.0% on a year-over-year basis. Equities analysts expect that UiPath Inc. will post -0.23 earnings per share for the current year.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.